Murphy Pohlad Asset Management’s Moderna MRNA Stock Holding History

Murphy Pohlad Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Buy	+3,824	New	+$198K	0.09%	123
2024 Q3	–	Sell	-2,000	Closed	-$238K	–	121
2024 Q2	$238K	Hold	2,000	–	–	0.1%	105
2024 Q1	$213K	Sell	2,000 -50	-2%	-$5.04K	0.08%	110
2023 Q4	$204K	Buy	2,050 +50	+3%	+$4.21K	0.08%	108
2023 Q3	$207K	Sell	2,000 -215	-10%	-$24K	0.09%	106
2023 Q2	$269K	Hold	2,215	–	–	0.12%	100
2023 Q1	$340K	Hold	2,215	–	–	0.14%	96
2022 Q4	$398K	Hold	2,215	–	–	0.16%	97
2022 Q3	$261K	Buy	+2,215	New	+$336K	0.12%	102

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Murphy Pohlad Asset Management's MRNA Position: Q2 2026 in Review

Murphy Pohlad Asset Management opened a new position in Moderna (MRNA) in Q2 2026: 3,824 shares worth $268K. The stake represents 0.09% of the portfolio and ranks #123 among its holdings. This is a return to the name: Murphy Pohlad Asset Management previously reported a position in MRNA as recently as Q2 2024.

Murphy Pohlad Asset Management first reported a position in MRNA in Q3 2022 and has held it in 9 quarters since. The position peaked at $398K in Q4 2022. 171 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Murphy Pohlad Asset Management held 3,824 shares of Moderna worth $268K as of Q2 2026.
Moderna was a new Murphy Pohlad Asset Management position in Q2 2026.
Moderna made up 0.09% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #123 holding.
Murphy Pohlad Asset Management first reported a position in Moderna in Q3 2022 and has held it in 9 quarters since.
Murphy Pohlad Asset Management's Moderna position peaked at $398K in Q4 2022.
171 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.